72 related articles for article (PubMed ID: 7243173)
1. Ultrastructural and clinical observations on skin metastases from breast cancer patients following intralesional treatment with MER/BCG vaccine.
Bar-Sella P; Bartal A; Robinson E; Nir I
Oncology; 1981; 38(4):198-203. PubMed ID: 7243173
[TBL] [Abstract][Full Text] [Related]
2. [Ultrastructural changes in breast cancer metastases following intralesional injections of MER].
Bar-Sella P; Nir I; Bartal A; Robinson E
Harefuah; 1980 Dec; 99(12):413-5. PubMed ID: 7250842
[No Abstract] [Full Text] [Related]
3. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
[TBL] [Abstract][Full Text] [Related]
4. Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma.
Krown SE; Hilal EY; Pinsky CM; Hirshaut Y; Wanebo HJ; Hansen JA; Huvos AG; Oettgen HF
Cancer; 1978 Dec; 42(6):2648-60. PubMed ID: 728866
[TBL] [Abstract][Full Text] [Related]
5. Intralesional immune therapy: methanol extraction residue of BCG or purified protein derivative.
Lokich JJ; Garnick MB; Legg M
Oncology; 1979; 36(5):236-41. PubMed ID: 481845
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.
Hanna MG; Peters LC
Cancer; 1975 Oct; 36(4):1298-304. PubMed ID: 1175128
[TBL] [Abstract][Full Text] [Related]
7. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
[No Abstract] [Full Text] [Related]
8. Alterations of the clinically noninvolved skin in patients with malignant melanoma. An electron microscopic study before and after repeated application of BCG.
Szekeres L; Orfanos CE
Dermatologica; 1978; 156(3):142-54. PubMed ID: 624428
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
[TBL] [Abstract][Full Text] [Related]
10. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
11. Positive therapeutic response to BCG or to its soluble fraction F70 in some patients with carcinoma of the skin, of the breast or of the larynx.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):43-8. PubMed ID: 944214
[No Abstract] [Full Text] [Related]
12. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
13. Oral administration of the methanol extraction residue of BCG (MER/BCG): a phase I study in non-oat cell lung cancer patients.
Bartal AH; Mordohovich D; Lichtig C; Mekori T; Robinson E
Int J Immunopharmacol; 1983; 5(4):329-34. PubMed ID: 6629593
[TBL] [Abstract][Full Text] [Related]
14. Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
Hess AD; Catchatourian R; Zander AR; Epstein RB
Cancer Res; 1977 Nov; 37(11):3990-4. PubMed ID: 143344
[TBL] [Abstract][Full Text] [Related]
15. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
Seigler HF; Shingleton WW; Pickrell KL
Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
[TBL] [Abstract][Full Text] [Related]
16. Novel approach to MER/BCG administration in cancer patients.
Bartal AH; Robinson E
Cancer Invest; 1987; 5(1):1-5. PubMed ID: 3580942
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
Grigorovich NA; Risina DIa; Nodel'son SE
Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lung cancer by radiotherapy, chemotherapy, and methanol extraction residue of BCG (MER): clinical and immunological studies.
Robinson E; Bartal A; Cohen Y; Haasz R; Mekori T
Cancer; 1977 Sep; 40(3):1052-9. PubMed ID: 902232
[TBL] [Abstract][Full Text] [Related]
19. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
Fon GT; Bein ME; Holmes EC; Huberman RP
AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
Berd D; Maguire HC; McCue P; Mastrangelo MJ
J Clin Oncol; 1990 Nov; 8(11):1858-67. PubMed ID: 2230873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
